Ordinary Adjustment | Julius Baer Next Generation Healthy China Index | Effective Date 8th January 2025
Julius Baer Next Generation Healthy China Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th January 2025:
| 3SBIO INC |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
| BEIGENE LTD |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| CHINA RESOURCES PHARMACEUTICAL |
| CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD |
| CSPC PHARMACEUTICAL GROUP LTD |
| HANSOH PHARMACEUTICAL GROUP CO |
| HUTCHMED CHINA LTD |
| INNOVENT BIOLOGICS INC |
| JD HEALTH INTERNATIONAL INC |
| MICROPORT SCIENTIFIC CORP |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SINOPHARM GROUP CO LTD |
| WUXI APPTEC CO LTD |
| WUXI BIOLOGICS CAYMAN INC |
| ZAI LAB LTD |